. Flowchart of study selection process. Of 133 studies in the NCBI BioProject 83
Sequence Read Archive as of August 1, 2019, seven met study selection criteria. One 84 additional study was identified in the research upload site Zenodo 85 (https://zenodo.org/). 86 We extended the HYDRA pipeline [14] to generate a codon frequency table from each 87 FASTQ file. Briefly, we filtered reads with fewer than 100 nucleotides or a mean quality (phred or 88 q) score <30 (predicted error rate 1 in 1000). We then aligned the filtered reads to the HXB2 pol 89 nucleotide sequence using BOWTIE 2 [15] with the default HYDRA parameters. Individual 90 nucleotides with a q score lower than 30 were not counted. Positions covered with 1000 9 138 all amino acid mutations that would result from APOBEC3F or 3G editing of these potential 139 targets. Each of the resulting APOBEC-context mutations were then examined for their 140 prevalence in group M sequences and for their association with stop codons or active site 
146
APOBEC-context mutations that met the following criteria were considered signature 147 APOBEC mutations: (i) they occurred at a prevalence <0.1% or at a prevalence <0.5% if they 148 occurred frequently in sequences with stop codons or active site mutations and (ii) they were not 
188
The median proportion of positions with a usual mutation increased from 5.2% to 11.6% 189 between the 20% and 0.5% thresholds then began doubling to 23.6% at the 0.2% threshold and 190 to 47.2% at the 0.1% thresholds.
191
The median proportion of positions with an unusual mutation increased from 0% to 0.3% 192 between the 20% and 1% thresholds but then began increasing about four-fold to 1.3% at the 193 0.5% threshold, 6.9% at the 0.2% threshold, and 23.2% at the 0.1% thresholds.
194
The median proportion of mutations that were unusual (number of unusual mutations / 195 [number of usual mutations + number of unusual mutations]) increased from 0% to 1.1%
196 between the 20% and 2% threshold but then jumped to 4.2% at the 1% threshold, 12.0% at the 197 0.5% threshold, and to 25.1%, and 33.9% respectively at the 0.2% and 0.1% thresholds.
198
There was a weak but statistically significant relationship between the log 10 of the number 199 of sequence reads (i.e., coverage) and the number of usual mutations (correlation coefficient r 200 between 0.21 and 0.24, p<0.001) at the 1%, 2%, 5%, 10%, and 20% thresholds (Supplementary 201 Figure 1) . The relationship between the number of sequence reads and the number of unusual 202 mutations was much weaker with r between 0.13 and 0.17 at the 1%, 2%, and 5% thresholds 203 ( Supplementary Figure 2) . 
255
Although the complete set of signature APOBEC mutations (n=296) was much smaller 256 than the complete set of unusual mutations that were not signature APOBEC mutations 257 (n=14,940), signature APOBEC mutations outnumbered non-APOBEC unusual mutations in 258 16.0%, 17.3%, and 13.2% of samples at the 0.5%, 1%, and 2% thresholds, but in just 2.8% to 7.5% 259 of samples at the remaining thresholds ( Figure 6 ). 270 increased gradually from 0% to 0.3% between the 20% and 1% thresholds and then exponentially 271 to 1.3%, 6.9%, and 23.2% at the 0.5%, 0.2%, and 0.1% thresholds, respectively. Similarly, the 272 proportion of mutations that were unusual increased gradually from 0% to 1.1% between the 273 20% and 2% threshold but then exponentially to 4.2%, 12.0%, and 25.1%, at the 1%, 0.5%, and 274 0.2% thresholds, respectively.
275
The marked increase in the proportion of positions with unusual mutations and in the 276 proportion of mutations that were unusual at detection thresholds below 1% suggests that many 277 of the mutations at low thresholds resulted from processes other than virus replication such as 278 PCR error and APOBEC-mediated hypermutation. Moreover, in two of the studies for which 279 plasma HIV-1 RNA levels were available, the proportion of positions with unusual mutations was 280 inversely related to virus levels at the 0.5%, 1%, 2%, and 5% thresholds. A plausible explanation 281 for this pattern is that samples with lower virus loads yield fewer cDNA molecules and that, in 282 these samples, a greater amount of sequence variation results from PCR amplification rather than 283 from HIV-1 replication.
284
Illumina sequence errors were also likely to have contributed to sequence artifact but 285 only in those samples for which the read coverage was too low to achieve the redundancy 21 286 required to prevent random machine errors from being detected at low thresholds. Indeed, over 287 the complete dataset, the median coverage per position was 18,275 and 95% of positions had a 288 coverage of nearly 3,000 reads. Thus for 95% of samples, machine error would have required the 289 same random error to occur at least three times to result in detectable sequence artifacts at the 290 0.1% threshold and at least six times to reach the 0.2% threshold. The observation that read 291 coverage was not correlated with the proportion of positions with unusual mutations also 292 supports the conclusion that most unusual mutations did not result from machine error.
293
APOBEC-mediated G-to-A hypermutation is not a result of PCR error and it presents in 329 Third, co-occurrence of low abundance variants can be used to increase the confidence of each
